Last update 06 Nov 2024
FM-101
Last update 06 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms 20ND02, FM 101, FM-101 |
Target |
Mechanism A3R modulators(Adenosine A3 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC16H15Cl2N5O2S |
InChIKeyJQUBXCDDRXAMLF-IXPVHAAZSA-N |
CAS Registry945457-84-1 |
Related
4
Clinical Trials associated with FM-101A Randomized Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of FM101 in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis
Phase 1/2a, Randomized, Double-Masked, Placebo-Controlled, Multi-center Study Assessing the Safety, Tolerability, And Efficacy Of FM101 In Patients With Ocular Hypertension, And To Assess The Relative Bioavailability Of The FM101 Oral Tablet Formulation In Healthy Participants
A study to assess the safety, tolerability, and pharmacokinetics of FM101 after single and multiple ascending dose administration to healthy subjects.
100 Clinical Results associated with FM-101
Login to view more data
100 Translational Medicine associated with FM-101
Login to view more data
100 Patents (Medical) associated with FM-101
Login to view more data
100 Deals associated with FM-101
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glaucoma | Phase 2 | KR | 30 Jan 2022 | |
| Nonalcoholic Steatohepatitis | Phase 2 | HU | 10 Jun 2021 | |
| Nonalcoholic Steatohepatitis | Phase 2 | PL | 10 Jun 2021 | |
| Nonalcoholic Steatohepatitis | Phase 2 | ES | 10 Jun 2021 | |
| Ocular Hypertension | Phase 2 | AU | 07 Oct 2020 | |
| Chronic Kidney Diseases | Phase 1 | KR | 30 Jan 2022 | |
| Liver Cirrhosis, Biliary | Phase 1 | KR | 30 Jan 2022 | |
| Hepatitis | Preclinical | KR | 12 Feb 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free